2015
DOI: 10.1016/j.cell.2015.09.001
|View full text |Cite
|
Sign up to set email alerts
|

Nuclear FAK Controls Chemokine Transcription, Tregs, and Evasion of Anti-tumor Immunity

Abstract: SummaryFocal adhesion kinase (FAK) promotes anti-tumor immune evasion. Specifically, the kinase activity of nuclear-targeted FAK in squamous cell carcinoma (SCC) cells drives exhaustion of CD8+ T cells and recruitment of regulatory T cells (Tregs) in the tumor microenvironment by regulating chemokine/cytokine and ligand-receptor networks, including via transcription of Ccl5, which is crucial. These changes inhibit antigen-primed cytotoxic CD8+ T cell activity, permitting growth of FAK-expressing tumors. Mechan… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

12
356
2

Year Published

2016
2016
2023
2023

Publication Types

Select...
8
2

Relationship

1
9

Authors

Journals

citations
Cited by 315 publications
(370 citation statements)
references
References 48 publications
12
356
2
Order By: Relevance
“…However, in a murine breast cancer model with CCL5 knockdown in tumor cells only, no differences in tumor growth or metastasis occurred (63). However, in squamous cell carcinoma, knockdown of CCL5 leads to tumor regression and reduced numbers of recruited Treg cells (64). Further, knockdown of CCL5 in murine colorectal carcinoma cells delays tumor growth and decreases both Treg cell infiltration and CD8 ϩ T-cell apoptosis (65).…”
Section: Journal Of Biological Chemistry 4101mentioning
confidence: 99%
“…However, in a murine breast cancer model with CCL5 knockdown in tumor cells only, no differences in tumor growth or metastasis occurred (63). However, in squamous cell carcinoma, knockdown of CCL5 leads to tumor regression and reduced numbers of recruited Treg cells (64). Further, knockdown of CCL5 in murine colorectal carcinoma cells delays tumor growth and decreases both Treg cell infiltration and CD8 ϩ T-cell apoptosis (65).…”
Section: Journal Of Biological Chemistry 4101mentioning
confidence: 99%
“…3E) that could be exploited in the treatment of GBM. For instance, targeting FAK, effectors of EMT or components of the glycocalyx, each of which are being examined as targets in clinical trials (Hingorani et al, 2016;Traber et al, 2013;Serrels et al, 2015), could improve disease outcome when combined with standard-of-care treatment. These findings also suggest that, similar to what has been shown for solid tumors (Acerbi et al, 2015), mechanical testing or assessment of mechanosignaling of gliomas can extend the repertoire of conventional molecular biomarkers, thereby improving predictions of response to therapy.…”
Section: Effects Of Mechanical Changes On Glioma Progressionmentioning
confidence: 99%
“…One that stood out was FAK, a nonreceptor tyrosine kinase that is overexpressed and/or hyperactive in many different cancer cell types, where it has been shown to participate in the maintenance of the transformed phenotype, including the evasion of apoptosis and promotion of anchorage-independent growth (23)(24)(25)(26)(27). In fact, targeting FAK for inactivation is currently being used as a strategy to treat several different types of human cancer (28,29). Fig.…”
Section: Onco-dbl Expression In Mefs Induces Cellular Transformation-mentioning
confidence: 99%